[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-ketaishengwu":3},{"head":4,"company":35,"invest":40,"children":41,"shops":42,"category":43,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":5,"industry":5,"brandType":5,"brandHonor":5,"brandTel":5,"establishdate":11,"brandBirth":12,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":13,"status":14,"isDeleted":14,"comment":5,"remark":5,"logoExistStatus":15,"imageExistStatus":15,"industryId":5,"industryRanking":5,"score":5,"enterName":16,"mallShopList":17,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":18,"pagekeywords":19,"pagedesc":20,"brandContent":21,"province":5,"city":5,"area":5,"detailaddress":22,"unifiedscc":23,"enterType":24,"enterLegalperson":25,"enterStablishdate":26,"regauthority":27,"licenseValidity":28,"approvaldate":29,"regcapital":30,"incapital":30,"businessscope":31,"ownBrand":5,"enterTelphone":32,"enterWebsite":5,"business":33,"enterQq":5,"enterMail":34,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"49039","\u002Fprofile\u002Fupload\u002F2025\u002F01\u002F25\u002F9bf13dc8ca58391779c0a222fb550f3e.gif","科泰生物","ketaishengwu",42279,"2008年","本溪市",200,0,"1","辽宁科泰生物基因制药股份有限公司",[],"科泰中成药品牌简介_科泰医药怎么样→品牌之家","科泰生物,科泰医药,科泰化学药品,科泰中成药,科泰保健品","科泰保健品品牌简介，品牌之家为您推荐科泰生物品牌历程、产品价格、口碑评价等内容。","辽宁科泰生物基因制药股份有限公司成立于2008年10月，为高科技股份制拟上市公司，位于辽宁生物医药科技产业基地香槐路，占地面积30万平方米，为生物制品、化学药品、中成药、保健品等产品研发、生产、销售的综合型高科技制药企业，拥有符合新版GMP标准的生产线十余条，日产9万支，年生产能力可达到3000万支以上。现公司产品主要涉及心脑血管疾病、糖尿病等相关代谢综合症、抗肿瘤、抗细菌或病毒感染等治疗领域。\n\n辽宁科泰生物制药分别于2000年5月9日，成立沈阳昆仑新药研发中心；2002年3月21日，成立北京昆仑医药研发中心；2008年7月7日成立沈阳昆泰新药技术开发有限公司，以此形成系统的化学小分子药物、生物基因药物和中医药物研究开发平台。随后，公司又投入巨资建立国际CRO动物实验室、国际CRO医药研发中心、DDS药物工程研发中心，先后组织完成第二代系列已知靶位单抗药物的开发和I期临床试验；完成缓释艾塞那肽注射液、DNJ吸入性粉雾剂、D1肽的药物传输系统的研究。同时，公司面向海外，利用国际合作，提高单抗药物、生物基因药物、极低计量药物等医药前段领域的研究开发。辽宁科泰除了大力打造企业研发团队外，还整合国内科研院校资源，先后开展与国内优质药业科研单位的合作，并形成较高的科研成果转化能力，部分产品在开展国内合作的同事，辽宁科泰也分项海外合作成果，与众多公司等联合创立海外科研创新团队，并取得多项重大开发研究成果。","本溪经济开发区香槐路106号","91210500680067179D","股份有限公司(港澳台投资、未上市)","连伟","2008-10-22","本溪市工商行政管理局","-","2020-12-29","13,615.4321万(元)","大容量注射剂、小容量注射剂、片剂、硬胶囊剂、软胶囊剂、颗粒剂、原料药（盐酸奥洛他定、雷奈酸锶、甲磺酸帕珠沙星）、茶剂生产；粉针剂（抗生素类）、原料药（盐酸氨溴索、门冬氨酸鸟氨酸、二羟二丁基醚、卵磷脂络合碘）生产；生物制药技术开发、技术合作、技术转让、技术服务；开发生产医药中间体；自营和代理各类商品及技术进出口。（依法须经批准的项目，经相关部门批准后方可开展经营活动。）","024-45567944","零售业","Ketai21@163.com",{"enterId":36,"enterName":16,"province":5,"city":5,"area":5,"detailaddress":22,"unifiedscc":23,"enterType":24,"enterLegalperson":25,"enterStablishdate":26,"regauthority":27,"licenseValidity":28,"approvaldate":29,"regcapital":30,"incapital":30,"businessscope":31,"ownBrand":5,"enterTelphone":32,"enterWebsite":5,"business":33,"performance":37,"socialSecurity":38,"registrationNumber":39,"enterQq":5,"enterMail":34,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":14,"regtrademark":5,"remark":5},"42279","开业","0人","210000004940443",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[]]